Beyfortus 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FX4J1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,336
Award facts
- Contract value 100% obligated
- $19,335.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,335.66 on January 20, 2026, for Beyfortus 100 mg/ml syringes. The Defense Logistics Agency funded this firm fixed-price contract, which is not set aside for any specific business category. This award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The contract is expected to be completed by January 21, 2026.
Beyfortus (respiratory syncytial virus monoclonal antibody) is a specialized immunization product used to protect infants and young children from respiratory syncytial virus infection. As the primary pharmaceutical supplier under the DLA Troop Support Medical IDC, Cencora, Inc. and its subsidiary AmerisourceBergen Drug Corp provide essential medications and medical supplies to military treatment facilities, the Defense Health Agency, and other federal healthcare systems worldwide. This delivery order exemplifies the type of critical specialized pharmaceutical commodity delivered through the comprehensive global pharmaceutical support vehicle that enables efficient medical supply distribution across Department of Defense healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FX4J1?
SPE2DR26FX4J1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FX4J1 worth?
The government has obligated $19,336 on SPE2DR26FX4J1.
Is contract SPE2DR26FX4J1 an order under another contract?
Yes. SPE2DR26FX4J1 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4J1 competed?
The extent of competition for SPE2DR26FX4J1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award